Conventional versus modified morphologic criteria for ganglioneuroblastoma: A review of cases from the pediatric oncology group

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 9, 1996, Pages 859-865

  Joshi, Vijay V ^a,g   Cantor, Alan B ^b   Altshuler, Geoffrey ^c   Cohen, Lewis J ^d   Larkin, Ernest W ^a   Shuster, J J ^b   Rao, P V ^b   Holbrook, C Tate ^a   Hayes, F Ann ^e   Castleberry, Robert P ^f  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Maine Children's Cancer Program Portland   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER SURVIVAL; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PROGNOSIS;

GANGLIONEUROBLASTOMA; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 10144238990     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dehner LP. Peripheral and central primitive neuroectodermal tumors: a nosologic concept seeking a consensus. Arch Pathol Lab Med. 1986;110:997-1005.
2. Willis RA. Pathology of Tumors. London, England: Butterworths; 1967:857-885.
3. Russell DS, Rubinstein LJ. Pathology of Tumors of the Nervous System. 5th ed. Baltimore, Md: Williams and Wilkins; 1989:898-944.
4. Dehner LP. Pediatric Surgical Pathology. 2nd ed. Baltimore, Md: Williams and Wilkins; 1987:562-574.
5. Harkin JC, Reed RJ. Tumors of the Peripheral Nervous System: Atlas of Tumor Pathology. 2nd series, fascicle 3. Armed Forces Institute of Pathology; 137-149.
6. Adam A, Hochholzer L. Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer. 1981;47:373-381.
7. Enzinger FM, Weiss SW. Soft Tissue Tumors. St Louis, Mo: CV Mosby Co; 1983:657-675.
8. Machin GA; Pochedy C, ed. Histogenesis and Histomorphology of Neuroblastoma - Clinical and Biological Manifestations. New York, NY: Elsever Biomedical; 1982:195-231.
9. Stout AP. Ganglioneuroma of the sympathetic nervous system. Surg Gynecol Obstet. 1947;84:101-110.
10. Bove KE, McAdams AJ. Composite ganglioneuroblastoma: an assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy. Arch Pathol Lab Med. 1981;105:325-330.
11. Shimada H, Chatten J, Newton WH Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73: 405-416.
12. Joshi VV, Cantor AB, Altshuler G, et al. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification: a clinicopathologic study of 213 cases. Cancer. 1992;69:2183-2196.
13. Joshi VV, Cantor AB, Altshuler G, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer. 1992;69:2197-2211.
14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials, part II: analysis and examples. Br J Cancer. 1977;35:1-39.
15. Joshi VV. Pathology of neuroblastic tumors. Semin Diagn Pathol. 1994;11: 107-117.